Adenomatous polyposis coli determines sensitivity to the EGFR tyrosine kinase inhibitor gefitinib in colorectal cancer cells

By Zhang Yining   Xiao Qinghuan   Zhang Huijing   Sun Xuren   Ge Huijuan   Liu Xiaoming   Guan Lin   Sun Mingjun  

Oncology Reports, Vol. 31, Iss. 4, 2014-04 ,pp. : 1811-1817

Spandidos Publications

Access to resources Recommend Favorite

Ad-p53 enhances the sensitivity of triple-negative breast cancer MDA-MB-468 cells to the EGFR inhibitor gefitinib

By  

Oncology Reports, Vol. 33, Iss. 2, 2015-01 ,pp. : 526-532

Spandidos Publications

Access to resources Recommend Favorite

Continuous exposure of nonsmall cell lung cancer cells with wildtype EGFR to an inhibitor of EGFR tyrosine kinase induces chemoresistance by activating STAT3

By                  

International Journal of Oncology, Vol. 46, Iss. 5, 2015-01 ,pp. : 2083-2095

Spandidos Publications

Access to resources Recommend Favorite

Hsp90 inhibitor NVP-AUY922 enhances the radiation sensitivity of lung cancer cell lines with acquired resistance to EGFR-tyrosine kinase inhibitors

By  

Oncology Reports, Vol. 33, Iss. 3, 2015-01 ,pp. : 1499-1504

Spandidos Publications

Access to resources Recommend Favorite

Combined gefitinib and pemetrexed overcome the acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer

By        

Molecular Medicine Reports, Vol. 10, Iss. 2, 2014-01 ,pp. : 931-938

Spandidos Publications

Access to resources Recommend Favorite